Litcius/Paper detail

Apixaban and rivaroxaban in obese patients treated for venous thromboembolism: Drug levels and clinical outcomes

Alice Ballerie, Rémi Nguyen Van, Karine Lacut, Hubert Galinat, Chloé Rousseau, Adeline Pontis, Fabienne Nédelec-Gac, Alain Lescoat, Nicolas Belhomme, Pierre Guéret, Guillaume Mahé, Françis Couturaud, P. Jégo, Isabelle Gouin‐Thibault

2021Thrombosis Research20 citationsDOIOpen Access PDF

Topics & Concepts

RivaroxabanApixabanMedicineProspective cohort studyInternal medicineVenous thrombosisVenous thromboembolismThrombosisSurgeryWarfarinAtrial fibrillationVenous Thromboembolism Diagnosis and ManagementAtrial Fibrillation Management and OutcomesBlood Coagulation and Thrombosis Mechanisms
Apixaban and rivaroxaban in obese patients treated for venous thromboembolism: Drug levels and clinical outcomes | Litcius